These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37887249)

  • 1. Time-Kill Analysis of Canine Skin Pathogens: A Comparison of Pradofloxacin and Marbofloxacin.
    Azzariti S; Mead A; Toutain PL; Bond R; Pelligand L
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
    Serrano-Rodríguez JM; Fernández-Varón E; Rodríguez CMC; Andrés-Larrea MIS; Rubio-Langre S; de la Fe C; Dova SW; Bhardwaj P; Sidhu PK; Litterio NJ; Lorenzutti AM
    Res Vet Sci; 2023 Jun; 159():1-10. PubMed ID: 37060837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat.
    Lees P
    J Vet Pharmacol Ther; 2013 Jun; 36(3):209-21. PubMed ID: 23406008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
    Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
    Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity of pradofloxacin and marbofloxacin against coagulase-positive staphylococci in a pharmacokinetic-pharmacodynamic model based on canine pharmacokinetics.
    Körber-Irrgang B; Wetzstein HG; Bagel-Trah S; Hafner D; Kresken M
    J Vet Pharmacol Ther; 2012 Dec; 35(6):571-9. PubMed ID: 22276681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of canine methicillin-resistant Staphylococcus pseudintermedius strains to pradofloxacin.
    Kizerwetter-Świda M; Chrobak-Chmiel D; Rzewuska M; Binek M
    J Vet Diagn Invest; 2016 Sep; 28(5):514-8. PubMed ID: 27449131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
    Liu X; Boothe DM; Jin Y; Thungrat K
    World J Microbiol Biotechnol; 2013 Feb; 29(2):347-54. PubMed ID: 23136054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals.
    Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S
    Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.
    Rubio-Langre S; Aguilar-Sola S; Lorenzutti AM; San Andrés MI; De Lucas JJ; Litterio NJ
    J Vet Pharmacol Ther; 2018 Dec; 41(6):861-870. PubMed ID: 30020535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole.
    Blondeau JM; Fitch SD
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal properties of pradofloxacin against veterinary pathogens.
    Silley P; Stephan B; Greife HA; Pridmore A
    Vet Microbiol; 2012 May; 157(1-2):106-11. PubMed ID: 22209121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefovecin, cefazolin, doxycycline and pradofloxacin.
    Blondeau JM; Shebelski SD
    Vet Dermatol; 2016 Aug; 27(4):267-e63. PubMed ID: 27307405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of oral pradofloxacin administration in dogs.
    Boothe DM; Bush KM; Boothe HW; Davis HA
    Am J Vet Res; 2018 Dec; 79(12):1268-1276. PubMed ID: 30457901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and
    Pelligand L; Lees P; Sidhu PK; Toutain PL
    Front Microbiol; 2019; 10():1237. PubMed ID: 31244793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study on the comparative minimum inhibitory and mutant prevention concentration values for moxifloxacin and pradofloxacin against canine and human isolates of Staphylococcus pseudintermedius and S. schleiferi.
    Plowgian C; Blondeau JM; Levinson M; Rosenkrantz W
    Vet Dermatol; 2019 Dec; 30(6):481-e142. PubMed ID: 31486554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
    Boothe DM; Boeckh A; Simpson RB; Dubose K
    J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.